CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection

European Journal of Immunology

Volumn 42, Issue 7, 2012, Pages 1755-1766

  Schmidt, Tina ^a   Dirks, Jan ^a   Enders, Martin ^b   Gärtner, Barbara C ^a   Uhlmann Schiffler, Heike ^a   Sester, Urban ^a   Sester, Martina ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b Infectious Diseases and Epidemiology eV   (Germany)

Author keywords

Cross reactivity; Immunity; Influenza; T cell; Vaccination

Indexed keywords

ANTIBODY; ANTIGEN; CD69 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INFLUENZA VACCINE; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 7 RECEPTOR;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; IMMUNOREACTIVITY; INFECTION CONTROL; INFLUENZA A (H1N1); INFLUENZA VACCINATION; NONHUMAN; PANDEMIC INFLUENZA; PRIORITY JOURNAL; SEASONAL INFLUENZA;

ADULT; ANTIBODIES, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNITY, CELLULAR; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTERFERON-GAMMA; INTERLEUKIN-2; MIDDLE AGED; NEUTRALIZATION TESTS; PANDEMICS; STATISTICS, NONPARAMETRIC;

EID: 84864023956     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201242393     Document Type: Article

References (34)

1. WHO, Influenza (Seasonal) Fact sheet No. 211, April 2009.
2. Bautista, E., Chotpitayasunondh, T., Gao, Z., Harper, S. A., Shaw, M., Uyeki, T. M., Zaki, S. R. et al., Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N. Engl. J. Med. 2010. 362: 1708-1719.
3. Gerhard, W., Mozdzanowska, K., Furchner, M., Washko, G.and Maiese, K., Role of the B-cell response in recovery of mice from primary influenza virus infection. Immunol. Rev. 1997. 159: 95-103.
4. Wrammert, J., Koutsonanos, D., Li, G. M., Edupuganti, S., Sui, J., Morrissey, M., McCausland, M. et al., Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 2011. 208: 181-193.
5. Hancock, K., Veguilla, V., Lu, X., Zhong, W., Butler, E. N., Sun, H., Liu, F. et al., Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med. 2009. 361: 1945-1952.
6. Glezen, W. P., How did the 2008-2009 seasonal influenza vaccine affect the pandemic? Clin. Infect Dis. 2010. 51: 1380-1382.
7. Johns, M. C., Eick, A. A., Blazes, D. L., Lee, S. E., Perdue, C. L., Lipnick, R., Vest, K. G. et al., Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel. PLoS One 2010. 5: e10722.
8. Garcia-Garcia, L., Valdespino-Gomez, J. L., Lazcano-Ponce, E., Jimenez-Corona, A., Higuera-Iglesias, A., Cruz-Hervert, P., Cano-Arellano, B. et al., Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City. Br. Med. J. 2009. 339: b3928.
9. De Groot, A. S., Ardito, M., McClaine, E. M., Moise, L.and Martin, W. D., Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-2009 conventional influenza vaccine. Vaccine 2009. 27: 5740-5747.
10. Wherry, E. J., T cell exhaustion. Nat. Immunol. 2011. 131: 492-499.
11. Sester, U., Fousse, M., Dirks, J., Mack, U., Prasse, A., Singh, M., Lalvani, A. et al., Whole-blood flow-cytometric analysis of antigen-specific CD4 T-cell cytokine profiles distinguishes active tuberculosis from non-active states. PLoS One 2011. 6: e17813.
12. Harari, A., Dutoit, V., Cellerai, C., Bart, P. A., Du Pasquier, R. A. and Pantaleo, G., Functional signatures of protective antiviral T-cell immunity in human virus infections. Immunol. Rev. 2006. 211: 236-254.
13. Sester, U., Presser, D., Dirks, J., Gärtner, B. C., Köhler, H.and Sester, M., PD-1 expression and IL-2 loss of cytomegalovirus-specific T cells correlates with viremia and reversible functional anergy. Am. J. Transplant. 2008. 8: 1486-1497.
14. Walker, W. T.and Faust, S. N., Monovalent inactivated split-virion AS03-adjuvanted pandemic influenza A (H1N1) vaccine. Expert Rev. Vaccines 2010. 9: 1385-1398.
15. Black, G. F., Weir, R. E., Floyd, S., Bliss, L., Warndorff, D. K., Crampin, A. C., Ngwira, B. et al., BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet 2002. 359: 1393-1401.
16. Busse, W. W., Peters, S. P., Fenton, M. J., Mitchell, H., Bleecker, E. R., Castro, M., Wenzel, S. et al., Vaccination of patients with mild and severe asthma with a 2009 pandemic H1N1 influenza virus vaccine. J. Allergy Clin. Immunol. 2011. 127: 130-137, 137 e131-133.
17. Treanor, J., Keitel, W., Belshe, R., Campbell, J., Schiff, G., Zangwill, K., Wolff, M. et al., Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults. Vaccine 2002. 20: 1099-1105.
18. Keynan, Y., Card, C. M., Ball, B. T., Li, Y., Plummer, F. A.and Fowke, K. R., Cellular immune responses to recurring influenza strains have limited boosting ability and limited cross-reactivity to other strains. Clin. Microbiol. Infect. 2010. 16: 1179-1186.
19. Subbramanian, R. A., Basha, S., Shata, M. T., Brady, R. C.and Bernstein, D. I., Pandemic and seasonal H1N1 influenza hemagglutinin-specific T cell responses elicited by seasonal influenza vaccination. Vaccine 2010. 28: 8258-8267.
20. Richards, K. A., Topham, D., Chaves, F. A.and Sant, A. J., Cutting edge: CD4 T cells generated from encounter with seasonal influenza viruses and vaccines have broad protein specificity and can directly recognize naturally generated epitopes derived from the live pandemic H1N1 virus. J. Immunol. 2010. 185: 4998-5002.
21. Ge, X., Tan, V., Bollyky, P. L., Standifer, N. E., James, E. A.and Kwok, W. W., Assessment of seasonal influenza A virus-specific CD4 T-cell responses to 2009 pandemic H1N1 swine-origin influenza A virus. J. Virol. 2010. 84: 3312-3319.
22. Greenbaum, J. A., Kotturi, M. F., Kim, Y., Oseroff, C., Vaughan, K., Salimi, N., Vita, R. et al., Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc. Natl. Acad. Sci. USA 2009. 106: 20365-20370.
23. Itoh, Y., Shinya, K., Kiso, M., Watanabe, T., Sakoda, Y., Hatta, M., Muramoto, Y. et al., In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009. 460: 1021-1025.
24. Guo, H., Santiago, F., Lambert, K., Takimoto, T.and Topham, D. J., T cell-mediated protection against lethal 2009 pandemic H1N1 influenza virus infection in a mouse model. J. Virol. 2011. 85: 448-455.
25. Chen, G. L., Lau, Y. F., Lamirande, E. W., McCall, A. W.and Subbarao, K., Seasonal influenza infection and live vaccine prime for a response to the 2009 pandemic H1N1 vaccine. Proc. Natl. Acad. Sci. USA 2011. 108: 1140-1145.
26. Sun, K., Ye, J., Perez, D. R.and Metzger, D. W., Seasonal FluMist vaccination induces cross-reactive T cell immunity against H1N1 (2009) influenza and secondary bacterial infections. J. Immunol. 2011. 186: 987-993.
27. Steel, J., Staeheli, P., Mubareka, S., Garcia-Sastre, A., Palese, P.and Lowen, A. C., Transmission of pandemic H1N1 influenza virus and impact of prior exposure to seasonal strains or interferon treatment. J. Virol. 2010. 84: 21-26.
28. Miller, E., Hoschler, K., Hardelid, P., Stanford, E., Andrews, N.and Zambon, M., Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010. 375: 1100-1108.
29. Karageorgopoulos, D. E., Vouloumanou, E. K., Korbila, I. P., Kapaskelis, A.and Falagas, M. E., Age distribution of cases of 2009 (H1N1) pandemic influenza in comparison with seasonal influenza. PLoS One 2011. 6: e21690.
30. Wilkinson, T. M., Li, C. K., Chui, C. S., Huang, A. K., Perkins, M., Liebner, J. C., Lambkin-Williams, R. et al., Preexisting influenza-specific CD4(+) T cells correlate with disease protection against influenza challenge in humans. Nat. Med. 2012. 18: 274-280.
31. Jelley-Gibbs, D. M., Strutt, T. M., McKinstry, K. K.and Swain, S. L., Influencing the fates of CD4 T cells on the path to memory: lessons from influenza. Immunol. Cell Biol. 2008. 86: 343-352.
32. Waldrop, S. L., Davis, K. A., Maino, V. C.and Picker, L. J., Normal human CD4+ memory T cells display broad heterogeneity in their activation threshold for cytokine synthesis. J. Immunol. 1998. 161: 5284-5295.
33. Zielinska, E., Liu, D., Wu, H. Y., Quiroz, J., Rappaport, R.and Yang, D. P., Development of an improved microneutralization assay for respiratory syncytial virus by automated plaque counting using imaging analysis. Virol. J. 2005. 2: 84.
34. Rowe, T., Abernathy, R. A., Hu-Primmer, J., Thompson, W. W., Lu, X., Lim, W., Fukuda, K. et al., Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J. Clin. Microbiol. 1999. 37: 937-943.